These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21700414)

  • 1. Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians.
    Mittal RD; Srivastava P; Mittal T; Verma A; Jaiswal PK; Singh V; Mandal RK; Mandhani A
    Eur J Surg Oncol; 2011 Aug; 37(8):727-33. PubMed ID: 21700414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death receptor 4 variants and colorectal cancer risk.
    Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of caspases with an increased prostate cancer risk in north Indian population.
    Mittal RD; Mittal T; Singh AK; Mandal RK
    DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
    Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
    Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
    Gangwar R; Mandhani A; Mittal RD
    Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort.
    Srivastava P; Mandhani A; Kapoor R; Mittal RD
    Ann Surg Oncol; 2010 Nov; 17(11):3068-75. PubMed ID: 20574775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
    Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India.
    George GP; Mandal RK; Kesarwani P; Sankhwar SN; Mandhani A; Mittal RD
    Urol Oncol; 2012; 30(6):781-9. PubMed ID: 21396853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the caspase-8 gene and the risk of lung cancer.
    Son JW; Kang HK; Chae MH; Choi JE; Park JM; Lee WK; Kim CH; Kim DS; Kam S; Kang YM; Park JY
    Cancer Genet Cytogenet; 2006 Sep; 169(2):121-7. PubMed ID: 16938569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death receptor 4 and bladder cancer risk.
    Hazra A; Chamberlain RM; Grossman HB; Zhu Y; Spitz MR; Wu X
    Cancer Res; 2003 Mar; 63(6):1157-9. PubMed ID: 12649168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
    Mittal RD; Manchanda PK; Bhat S; Bid HK
    BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
    Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
    Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
    Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
    Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
    Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
    Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.
    Zhang Z; Wang S; Wang M; Tong N; Fu G; Zhang Z
    Carcinogenesis; 2008 Oct; 29(10):1973-8. PubMed ID: 18684727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
    Bid HK; Manchanda PK; Mittal RD
    Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Urology; 2009 Mar; 73(3):675-80. PubMed ID: 19041121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.